two other segments, namely, prosthetics, and bracing and support. Foot & ankle prosthetics has gained a significant amount of footing since the introduction of technologically advanced devices and materials such as the pneumatic foot, carbon fiber, microprocessor-controlled, and hydraulic controlled prosthetic feet. Bracing and support consists of a large range of devices, utilized on the basis of type of injury. Braces are available for minor strains and twists, along with heavy-duty braces for postoperative recuperation.
The main drivers for the foot & ankle devices market are the rise in sports injuries, which commonly involve serious ankle injuries, increasing incidences of road accidents, and rise in rate of diabetes, which leads to the deterioration of foot & ankle area caused by large sores and infections. The foot & ankle extremity market will grow substantially in the coming decade with advances in technology.
Companies mentioned in this report include Aap Implantate Ag., Acumed Llc, Arthrex Inc., Arthrocare Corporation, Biomedical Enterprises Inc., Biomet Inc., Conmed Corporation (Conmed Linvatec), Core Essence Orthopaedic Inc., Deroyal Industries Inc., Donjoy Inc., Fh Orthopedics, Fillauer Inc., Integra Lifesciences Holding Corporation., Internal Fixation Systems Inc., Medartis, Ag., Mondeal Medical Systems Gmbh, Mueller Sports Medicine Inc., Ortho Europe, Orthofix International Nv., Orthopro Llc, Orthrocare Innovation Llc, Ossur, Ottobock Healthcare Gmbh., Small Bone Innovations Inc., Smith & Nephew Inc., Stryker Corporation, Synthes Inc., Tornier Bv, Vilex Inc., Wright Medical Technology Inc. and Zimmer Holdings, Inc.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Foot & Ankle Orthopedic Implants And Devices Market
5 Global Foot & Ankle Prosthetics Market
6 Global Foot & Ankle Bracing And Support Market
7 F
'/>"/>
Source: PRWeb Copyright©2012 Vocus, Inc. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond2.
Inflamax Research Appoints
Dr. Anne Marie Salapatek President & Chief Scientific Officer3.
Drivers of M&A in 2013-2016: PI3Ks and BTK Inhibitors4.
Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D5.
Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show6.
Genomatica and DuPont Tate & Lyle Bio Products Successfully Produce 1,4-Butanediol (BDO) on Commercial Scale7.
Plunketts Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies8.
Plunketts Biotech & Genetics Industry Trends & Statistics 2013: A Summary Version of Plunketts Biotech & Genetics Industry Almanac 20139.
Strand Raises Series B From Burrill & Company10.
Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET11.
Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference